COPD

COPD exacerbations are a clinical diagnosis that is often jumped to as the diagnosis in patients with COPD who have increasing dyspnea.

- The US Food and Drug Administration added new data to the Tudorza Pressair (aclidinium bromide inhalation powder) Prescribing Information that includes data from the ASCENT trial showing that Tudorza Pressair reduces exacerbations in chronic obstructive pulmonary disease and does not increase major adverse cardiovascular events in COPD patients with cardiovascular disease and/or significant cardiovascular risk factors, US-based Circassia Pharmaceuticals Inc said.

(5-7) The reasons for diagnostic error in COPD and asthma are multifactorial, stemming from insufficient knowledge of clinical practice guidelines and underutilization of spirometry testing.

The significant 11 relationship of high grade dyspnea with BMI (p=0.001), and MUAC (p=<0.001) revealed that malnourished COPD patients had more shortness of breathing as compared to normal-weight patients.

A Chronic obstructive pulmonary disease (COPD) does get progressively worse and may require more than one drug to control it as the lungs become more and more inelastic and unable to breathe in and out.

They said changes in weather had triggered asthma and COPD and the situation could be controlled through awareness campaigns, effective management and long-term treatment.

They said, 'Asthma and Chronic Obstructive Pulmonary Disease (COPD) are two of the most common respiratory diseases in Pakistan, posing a serious challenge.'

They said, 'Asthma and Chronic Obstructive Pulmonary Disease (COPD) are two of the most common respiratory diseases in Pakistan, posing a serious challenge.' Highlighting disease burden, they said that according to WHO estimates, 235 million people suffer from asthma worldwide while COPD is affecting 210 million people worldwide.

Previous research in people with HIV links COPD to worse breathing problems, hospital admission, and frailty.

Addressing a meeting organized by National Alliance for Tobacco Control in collaboration with the Aga Khan University (AKU) to commemorate the World COPD Day the speaker mentioned that the ailment affects more than 340 million people worldwide and represents the fourth leading cause of death, after , heart attacks, strokes and infectious diseases.

COPD day is organized by GOLD ( Global Initiative for Chronic Obstructive Lung Disease) every year in the month of November.